Differential gene expression of IFN-alpha and tumor necrosis factor-alpha in peripheral blood mononuclear cells from patients with AIDS related complex and AIDS

J Immunol. 1990 Feb 1;144(3):970-5.

Abstract

Human PBMC from HIV-1-infected individuals produced ex vivo in response to vesicular stomatitis virus only low amounts of IFN-alpha. This impairment was significant as early as Walter Reed (WR) stage 2; at WR stage 4-5, the production was almost zero. At WR stage 2 of infection, IFN-alpha mRNA was exclusively found in association with polyribosomes, indicating that IFN-alpha gene was transcriptionally inactive under the experimental conditions used. A similar decrease of the level of transcripts as a function of the progression of the disease was also observed for the IFN-gamma mRNA. In contrast, TNF-alpha production was strongly enhanced in PBMC from HIV-1-infected individuals after stimulation with LPS compared to the TNF-alpha production of activated PBMC from healthy donors. Almost parallel with the increase of the level of the transcript for TNF-alpha, the level of TNF-beta increases as well. Data are presented which show that the increased TNF-alpha production is due to a longer half-life of TNF-alpha transcripts in PBMC from infected individuals. These results let us suggest that the up-regulation of TNF-alpha gene expression in PBMC from HIV-infected individuals is controlled predominantly on the posttranscriptional level, whereas transcriptional events regulate the level of IFN-alpha transcripts. This assumption is supported by run-on experiments which revealed that the extent of transcription of TNF-alpha gene is almost identical in nuclei from stimulated PBMC of noninfected and HIV-infected donors, whereas the transcription of IFN-alpha gene is strongly suppressed in nuclei from HIV-infected individuals at WR stages 3 and 6.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS-Related Complex / genetics*
  • Acquired Immunodeficiency Syndrome / genetics*
  • Blotting, Northern
  • Gene Expression Regulation / drug effects
  • Humans
  • In Vitro Techniques
  • Interferon Type I / genetics*
  • Leukocytes, Mononuclear / physiology*
  • Lipopolysaccharides / pharmacology
  • RNA, Messenger / genetics
  • Tetradecanoylphorbol Acetate / pharmacology
  • Transcription, Genetic
  • Tumor Necrosis Factor-alpha / genetics*

Substances

  • Interferon Type I
  • Lipopolysaccharides
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Tetradecanoylphorbol Acetate